AUSTIN ROUBIDOUX: Open Payments
NPI 1760902571 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,525 in 75 payments from 22 companies in 2025. Trend: 2023 $225 · 2024 $1,019 · 2025 $1,525
Food & beverage: $1,525
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $181 |
| Ferring Pharmaceuticals Inc. | 6 | $162 |
| Merck Sharp & Dohme LLC | 6 | $134 |
| ABBVIE INC. | 7 | $115 |
| Dendreon Pharmaceuticals LLC | 5 | $106 |
| UROGEN PHARMA, INC. | 4 | $106 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| Sumitomo Pharma America, Inc. | 4 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $73 |
| Boston Scientific Corporation | 3 | $63 |
Products named: ERLEADA, ADSTILADRIN, BOTOX, PROVENGE, PLUVICTO, KEYTRUDA, GEMTESA, Nubeqa.
Industry payments across MO — which companies pay providers there.
